Last updated: January 10, 2024
Sponsor: Dr Adnan Agha
Overall Status: Active - Recruiting
Phase
2
Condition
Hormone Deficiencies
Female Hormonal Deficiencies/abnormalities
Thyroid Disease
Treatment
Oral Rehydration Salt Formulations
Vitamin C
Clinical Study ID
NCT05733078
UAEU_CMHS_IM_DOH_2023/56
Ages 18-99 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Age > 18; both male or female
- Diagnosed to have Primary hypothyroidism > 6 months.
- Under follow up in Endocrine clinic in Tawam hospital during the 6 months
- No evidence of secondary hypothyroidism (no pituitary problems/surgery or thyroidsurgery/ablation)
- TSH > 4 despite being on > 1.6 ug/kg/day of Levothyroxine for more than 8 weeks
Exclusion
Exclusion Criteria:
- Presence of coeliac disease
- Presence of selenium or iodine deficiency
- Gastric/intestinal resection surgery or confirmed malabsorption syndromes
- Known mental health issues affecting compliance
- Patient unable to consent.
- Overt biochemical hypothyroidism with TSH > 20 or T4 < 6
Study Design
Total Participants: 40
Treatment Group(s): 2
Primary Treatment: Oral Rehydration Salt Formulations
Phase: 2
Study Start date:
November 01, 2023
Estimated Completion Date:
June 30, 2024
Study Description
Connect with a study center
Internal Medicine, College of Medicine and Health Sciences
Al Ain, Abu Dhabi 15551
United Arab EmiratesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.